Susquehanna International Group, LLP Roivant Sciences Ltd. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 261,058 shares of ROIV stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
261,058
Previous 126,787
105.9%
Holding current value
$3 Million
Previous $1.5 Million
75.72%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$757 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$711 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$529 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$469 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$413 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.1B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...